Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells.
Journal Information
Full Title: Acta Pharmacol Sin
Abbreviation: Acta Pharmacol Sin
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"one replicate of raw data from ar and parental cells was deposited in the embl database under accession numbers e-mtab-5997 and e-mtab-7068.; others were deposited in the geo dataset under accession number gse142031.; raw data and processed data were deposited in the geo dataset under accession number gse142031."
"Competing interests The authors declare no competing interests."
"This research was funded by the National Key Research and Development Program of China (number 2018YFC1003501), the System Biomedicine Innovation Center Program from Shanghai Jiao Tong University (number 15ZH4009), the Key Translational Medicine Program from Shanghai Jiao Tong University School of Medicine (number 15ZH1008), and the National Natural Science Foundation of China (number 81874037)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025